putrescine has been researched along with Cancer of Prostate in 34 studies
Excerpt | Relevance | Reference |
---|---|---|
"To evaluate [1-11C]putrescine ([11C]PUT) as a potential tracer for imaging and characterization of human prostatic adenocarcinoma, positron emission tomography (PET) was performed in eight patients and three normal controls." | 7.69 | Positron emission tomography study of human prostatic adenocarcinoma using carbon-11 putrescine. ( Fowler, JS; MacGregor, RR; Madajewicz, S; Schlyer, DJ; Volkow, ND; Wang, GJ; Wolf, AP, 1994) |
"To evaluate [1-11C]putrescine ([11C]PUT) as a potential tracer for imaging and characterization of human prostatic adenocarcinoma, positron emission tomography (PET) was performed in eight patients and three normal controls." | 3.69 | Positron emission tomography study of human prostatic adenocarcinoma using carbon-11 putrescine. ( Fowler, JS; MacGregor, RR; Madajewicz, S; Schlyer, DJ; Volkow, ND; Wang, GJ; Wolf, AP, 1994) |
"Urinary excretion of the basic polyamine, spermidine, was significantly elevated in patients with prostatic carcinoma as compared to a control group of patients, Of 44 urine specimens from patients with prostatic malignancy 31 had spermidine levels more than 2 mg." | 3.65 | Urinary polyamine levels in the diagnosis of carcinoma of the prostate. ( Brorsson, U; Fair, WR; Wehner, N, 1975) |
"Putrescine is a small molecule that may prove difficult for use for synthesizing stable toxin derivatives that can take advantage of the targeting potential of the polyamine transporter." | 2.38 | Prostatic polyamines and polyamine targeting as a new approach to therapy of prostatic cancer. ( Heston, WD, 1991) |
"The strategy is applied to a prostate cancer patient cohort where data from MR spectroscopy and gene expression have been collected from and integrated on the exact same tissue samples." | 1.43 | A Balanced Tissue Composition Reveals New Metabolic and Gene Expression Markers in Prostate Cancer. ( Angelsen, A; Bathen, TF; Bertilsson, H; Drabløs, F; Rye, MB; Tessem, MB, 2016) |
"PCa, benign prostatic hyperplasia (BPH) patients and healthy controls (HC) showing PSA>4." | 1.43 | Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers. ( Chan, CF; Chan, WL; Chiu, KF; Ng, CF; Tsoi, TH; Wong, KL; Wong, WT, 2016) |
"Putrescine is a potential scanning agent for metastases of prostatic carcinoma." | 1.27 | alpha-Difluoromethylornithine enhancement of 14C-putrescine uptake by an androgen-dependent prostatic tumor. ( Heston, WD; Kadmon, D, 1986) |
"Putrescine was able to block the cytotoxic effect of AZP." | 1.27 | Cytotoxic activity of a polyamine analogue, monoaziridinylputrescine, against the PC-3 human prostatic carcinoma cell line. ( Covey, DF; Heston, WD; Pliner, L; Russo, P; Yang, CR, 1987) |
"There were 105 patients with these tumors; 319 polyamine determinations were obtained from this subset of patients." | 1.26 | Further evidence for the use of polyamines as biochemical markers for malignant tumors. ( Beal, SL; Horn, Y; Lubich, WP; Marton, LJ; Spigel, L; Walach, N, 1982) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (47.06) | 18.7374 |
1990's | 9 (26.47) | 18.2507 |
2000's | 7 (20.59) | 29.6817 |
2010's | 2 (5.88) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tessem, MB | 1 |
Bertilsson, H | 1 |
Angelsen, A | 1 |
Bathen, TF | 1 |
Drabløs, F | 1 |
Rye, MB | 1 |
Tsoi, TH | 1 |
Chan, CF | 1 |
Chan, WL | 1 |
Chiu, KF | 1 |
Wong, WT | 1 |
Ng, CF | 1 |
Wong, KL | 1 |
Basu, HS | 1 |
Thompson, TA | 1 |
Church, DR | 1 |
Clower, CC | 1 |
Mehraein-Ghomi, F | 1 |
Amlong, CA | 1 |
Martin, CT | 1 |
Woster, PM | 2 |
Lindstrom, MJ | 1 |
Wilding, G | 3 |
Desury, G | 1 |
Moulinoux, JP | 4 |
Delcros, JG | 1 |
Kee, K | 1 |
Vujcic, S | 1 |
Merali, S | 1 |
Diegelman, P | 1 |
Kisiel, N | 1 |
Powell, CT | 1 |
Kramer, DL | 1 |
Porter, CW | 1 |
Russo, A | 1 |
Piovano, M | 1 |
Clericuzio, M | 1 |
Lombardo, L | 1 |
Tabasso, S | 1 |
Chamy, MC | 1 |
Vidari, G | 1 |
Cardile, V | 1 |
Vita-Finzi, P | 1 |
Garbarino, JA | 1 |
Dunzendorfer, U | 2 |
Heston, WD | 7 |
Kadmon, D | 4 |
Covey, DF | 4 |
Fair, WR | 5 |
Lazan, DW | 1 |
Horn, Y | 2 |
Beal, SL | 1 |
Walach, N | 1 |
Lubich, WP | 1 |
Spigel, L | 2 |
Marton, LJ | 2 |
Smith, RC | 1 |
Litwin, MS | 1 |
Lu, Y | 1 |
Zetter, BR | 1 |
Brachet, P | 1 |
Quemener, V | 3 |
Havouis, R | 3 |
Tomé, D | 1 |
Cipolla, B | 2 |
Blanchard, Y | 1 |
Chamaillard, L | 1 |
Guillé, F | 2 |
Jeffers, L | 1 |
Church, D | 1 |
Basu, H | 1 |
Marton, L | 1 |
Wang, GJ | 1 |
Volkow, ND | 1 |
Wolf, AP | 1 |
Madajewicz, S | 1 |
Fowler, JS | 1 |
Schlyer, DJ | 1 |
MacGregor, RR | 1 |
Messing, EM | 1 |
Love, RR | 1 |
Tutsch, KD | 1 |
Verma, AK | 1 |
Douglas, J | 1 |
Pomplun, M | 1 |
Simsiman, R | 1 |
McCloskey, DE | 1 |
Casero, RA | 1 |
Davidson, NE | 1 |
Simoneau, AR | 1 |
Gerner, EW | 1 |
Phung, M | 1 |
McLaren, CE | 1 |
Meyskens, FL | 1 |
Srinath, P | 1 |
McQuarrie, SA | 1 |
Suresh, MR | 1 |
Welch, MJ | 3 |
Coleman, RE | 1 |
Straatmann, MG | 1 |
Asberry, BE | 1 |
Primeau, JL | 1 |
Ter-Pogossian, MM | 1 |
Sanford, EJ | 1 |
Drago, JR | 1 |
Rohner, TJ | 1 |
Kessler, GF | 1 |
Sheehan, L | 1 |
Lipton, A | 1 |
Wehner, N | 1 |
Brorsson, U | 1 |
Martin, C | 1 |
Lobel, B | 1 |
Seiler, N | 1 |
Hwang, DR | 2 |
Mathias, CJ | 2 |
McGuire, AH | 1 |
Knöner, M | 1 |
Lang, LX | 1 |
Yang, CR | 1 |
Pliner, L | 1 |
Russo, P | 1 |
Watanabe, KA | 1 |
Pankiewicz, KW | 1 |
Shukla, GS | 1 |
Singhal, RL | 1 |
Uy, L | 1 |
Mann, T | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Artificial Intelligence (AI)-Assisted Risk-based Prostate Cancer Detection: A Synergy of Novel Biomarkers, Advanced Imaging, and Robotic-assisted Diagnosis[NCT05443412] | 510 participants (Anticipated) | Observational | 2022-08-01 | Not yet recruiting | |||
To Evaluate the Performance of a Urine Spermine Measuring Device in Predicting Prostate Biopsy Result[NCT04339920] | 0 participants (Actual) | Observational | 2021-09-01 | Withdrawn (stopped due to No funding) | |||
To Investigate the Diagnostic Accuracy of Exosomal microRNA in Predicting the Aggressiveness of Prostate Cancer in Chinese Patients[NCT03911999] | 180 participants (Actual) | Observational | 2018-05-03 | Completed | |||
To Identify Potential New Urine Marker Panel for Cancer Screening[NCT04689802] | 2,500 participants (Anticipated) | Observational | 2021-01-20 | Recruiting | |||
To Investigate the Role of Gut Microbiome in Androgen Deprivation Therapy Related Metabolic Changes in Prostate Cancer Patients[NCT04687709] | 50 participants (Anticipated) | Observational | 2021-01-14 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 reviews available for putrescine and Cancer of Prostate
Article | Year |
---|---|
Prostatic polyamines and polyamine targeting as a new approach to therapy of prostatic cancer.
Topics: Aziridines; Biological Transport; Cell Division; Dihydrotestosterone; Eflornithine; Guanidines; Huma | 1991 |
Secretory function of the prostate, seminal vesicle and other male accessory organs of reproduction.
Topics: Acid Phosphatase; Animals; Body Fluids; Bulbourethral Glands; Cattle; Citrates; Dihydrotestosterone; | 1974 |
3 trials available for putrescine and Cancer of Prostate
Article | Year |
---|---|
Low-dose difluoromethylornithine and polyamine levels in human prostate tissue.
Topics: Administration, Oral; Antineoplastic Agents; Eflornithine; Enzyme Inhibitors; Humans; Male; Ornithin | 1999 |
Alpha-difluoromethylornithine and polyamine levels in the human prostate: results of a phase IIa trial.
Topics: Antineoplastic Agents; Chromatography, High Pressure Liquid; Eflornithine; Enzyme Inhibitors; Humans | 2001 |
Urinary polyamine levels in cancer patients treated with D,L-alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Evaluation; Eflornithine; Fem | 1989 |
29 other studies available for putrescine and Cancer of Prostate
Article | Year |
---|---|
A Balanced Tissue Composition Reveals New Metabolic and Gene Expression Markers in Prostate Cancer.
Topics: Biomarkers, Tumor; Citric Acid; Cohort Studies; Fatty Acids; Gene Expression Regulation, Neoplastic; | 2016 |
Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
Topics: Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Biopsy; Case-Control Studies; Chromato | 2016 |
Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
Topics: Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Biopsy; Case-Control Studies; Chromato | 2016 |
Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
Topics: Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Biopsy; Case-Control Studies; Chromato | 2016 |
Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
Topics: Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Biopsy; Case-Control Studies; Chromato | 2016 |
Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
Topics: Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Biopsy; Case-Control Studies; Chromato | 2016 |
Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
Topics: Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Biopsy; Case-Control Studies; Chromato | 2016 |
Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
Topics: Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Biopsy; Case-Control Studies; Chromato | 2016 |
Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
Topics: Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Biopsy; Case-Control Studies; Chromato | 2016 |
Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
Topics: Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Biopsy; Case-Control Studies; Chromato | 2016 |
Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
Topics: Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Biopsy; Case-Control Studies; Chromato | 2016 |
Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
Topics: Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Biopsy; Case-Control Studies; Chromato | 2016 |
Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
Topics: Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Biopsy; Case-Control Studies; Chromato | 2016 |
Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
Topics: Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Biopsy; Case-Control Studies; Chromato | 2016 |
Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
Topics: Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Biopsy; Case-Control Studies; Chromato | 2016 |
Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
Topics: Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Biopsy; Case-Control Studies; Chromato | 2016 |
Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
Topics: Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Biopsy; Case-Control Studies; Chromato | 2016 |
Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
Topics: Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Biopsy; Case-Control Studies; Chromato | 2016 |
Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
Topics: Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Biopsy; Case-Control Studies; Chromato | 2016 |
Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
Topics: Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Biopsy; Case-Control Studies; Chromato | 2016 |
Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
Topics: Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Biopsy; Case-Control Studies; Chromato | 2016 |
Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
Topics: Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Biopsy; Case-Control Studies; Chromato | 2016 |
Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
Topics: Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Biopsy; Case-Control Studies; Chromato | 2016 |
Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
Topics: Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Biopsy; Case-Control Studies; Chromato | 2016 |
Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
Topics: Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Biopsy; Case-Control Studies; Chromato | 2016 |
Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
Topics: Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Biopsy; Case-Control Studies; Chromato | 2016 |
A small molecule polyamine oxidase inhibitor blocks androgen-induced oxidative stress and delays prostate cancer progression in the transgenic adenocarcinoma of the mouse prostate model.
Topics: Acetyltransferases; Adenocarcinoma; Androgens; Animals; Cell Line, Tumor; Disease Models, Animal; Di | 2009 |
Alteration of intestinal putrescine uptake in tumour-bearing rats.
Topics: Amine Oxidase (Copper-Containing); Animals; Carbon Radioisotopes; Enterocytes; Intestinal Absorption | 2002 |
Metabolic and antiproliferative consequences of activated polyamine catabolism in LNCaP prostate carcinoma cells.
Topics: Acetyl Coenzyme A; Acetyltransferases; Adenosylmethionine Decarboxylase; Carcinoma; Cell Division; D | 2004 |
Putrescine-1,4-dicinnamide from Pholiota spumosa (Basidiomycetes) inhibits cell growth of human prostate cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Basidiomycota; Cell Line, Tumor; Cell Proliferation; Fruiting Bod | 2007 |
[Therapy of prostate carcinoma with polyamine synthesis inhibitors. I. Physiological and pathophysiological principles].
Topics: Antineoplastic Agents; Humans; Male; Polyamines; Prostatic Hyperplasia; Prostatic Neoplasms; Putresc | 1982 |
Differential effect of alpha-difluoromethylornithine on the in vivo uptake of 14C-labeled polyamines and methylglyoxal bis(guanylhydrazone) by a rat prostate-derived tumor.
Topics: Animals; Antineoplastic Agents; Biological Transport; Carbon Radioisotopes; Cells, Cultured; Eflorni | 1984 |
Aminoguanidine reversal of the inhibitory effects of ornithine analogs on the in vitro clonogenic survival of the R3327AT prostate-derived tumor.
Topics: Amine Oxidase (Copper-Containing); Animals; Carboxy-Lyases; Cell Line; Eflornithine; Guanidines; Mal | 1981 |
Further evidence for the use of polyamines as biochemical markers for malignant tumors.
Topics: Breast Neoplasms; Clinical Laboratory Techniques; Female; Genital Neoplasms, Female; Humans; Male; N | 1982 |
Identification of an endogenous inhibitor of prostatic carcinoma cell growth.
Topics: Adenocarcinoma; Animals; Enzyme Inhibitors; Growth Inhibitors; Guanidines; Humans; Male; Neoplasm In | 1995 |
Alterations in intestinal uptake of putrescine and tissue polyamine concentrations in tumor-bearing rats.
Topics: Adenocarcinoma; Animals; Body Weight; Dose-Response Relationship, Drug; Eating; Female; Intestinal A | 1994 |
In vivo, synergestic inhibition of MAT-LyLu rat prostatic adenocarcinoma growth by polyamine deprivation and low-dose cyclophosphamide.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Co | 1996 |
Effects of the polyamine analogues BE-4-4-4-4, BE-3-7-3, and BE-3-3-3 on the proliferation of three prostate cancer cell lines.
Topics: Animals; Antineoplastic Agents; Cell Division; Growth Inhibitors; Male; Mice; Mice, Nude; Polyamines | 1997 |
Positron emission tomography study of human prostatic adenocarcinoma using carbon-11 putrescine.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Carbon Radioisotopes; Humans; Male; Middle Aged; Prostatic Neo | 1994 |
Effects of the polyamine analogues N1-ethyl-N11-((cyclopropyl)methyl)-4,8-diazaundecane and N1-ethylN-11-((cycloheptyl)methyl)-4,8-diazaundecane in human prostate cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Division; DNA Fragmentation; Humans; Kinetics; Male; Polyamin | 2000 |
Comparative uptake of polyamines by prostate and non-prostate cancer cell lines.
Topics: Animals; Breast Neoplasms; Carbon Radioisotopes; Humans; Male; Ornithine; Polyamines; Prostatic Neop | 2002 |
Carbon-11-labeled methylated polyamine analogs: uptake in prostate and tumor in animal models.
Topics: Animals; Carbon Radioisotopes; Dogs; Male; Melanoma; Methylation; Mice; Neoplasm Transplantation; Ne | 1977 |
Preliminary evaluation of urinary polyamines in the diagnosis of genitourinary tract malignancy.
Topics: Adenocarcinoma; Carcinoma, Transitional Cell; Female; Humans; Kidney Neoplasms; Male; Polyamines; Pr | 1975 |
Urinary polyamine levels in the diagnosis of carcinoma of the prostate.
Topics: Aged; Carcinoma; Diagnosis, Differential; Electrophoresis, Paper; Humans; Male; Middle Aged; Polyami | 1975 |
The growth of MAT-LyLu rat prostatic adenocarcinoma can be prevented in vivo by polyamine deprivation.
Topics: Adenocarcinoma; Animals; Diet; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Eflorn | 1991 |
Imaging prostate derived tumors with PET and N-(3-[18F]fluoropropyl)putrescine.
Topics: Animals; Fluorine Radioisotopes; Humans; Male; Neoplasm Transplantation; Prostatic Neoplasms; Putres | 1990 |
[Therapy with inhibitors of polyamine biosynthesis in refractory prostatic carcinoma. An experimental and clinical study].
Topics: Adenocarcinoma; Adenosylmethionine Decarboxylase; Animals; Antineoplastic Agents; Carboxy-Lyases; Ca | 1985 |
N-3-[18F]fluoropropylputrescine as potential PET imaging agent for prostate and prostate derived tumors.
Topics: Animals; Carbon Radioisotopes; Cell Line; Dihydrotestosterone; Eflornithine; Humans; Male; Prostate; | 1989 |
alpha-Difluoromethylornithine enhancement of 14C-putrescine uptake by an androgen-dependent prostatic tumor.
Topics: Adenocarcinoma; Androgens; Animals; Carbon Radioisotopes; Dexamethasone; Dihydrotestosterone; Eflorn | 1986 |
Cytotoxic activity of a polyamine analogue, monoaziridinylputrescine, against the PC-3 human prostatic carcinoma cell line.
Topics: Cell Line; Cell Survival; Eflornithine; Humans; Kinetics; Male; Mathematics; Prostatic Neoplasms; Pu | 1987 |
Cytotoxic and non-cytotoxic N-alkyl derivatives of putrescine: effect on polyamine uptake and growth of prostatic cancer cells in vitro.
Topics: Alkylation; Cell Division; Cell Line; Humans; Male; Polyamines; Prostatic Neoplasms; Putrescine; Str | 1987 |
Hormone-independent polyamine metabolism of squamous cell carcinoma of the prostate.
Topics: Adenosylmethionine Decarboxylase; Androgens; Animals; Carcinoma, Squamous Cell; Castration; Cyproter | 1985 |
Cytotoxic activity of aziridinyl putrescine enhanced by polyamine depletion with alpha-difluoromethylornithine.
Topics: Antineoplastic Agents; Cell Line; Eflornithine; Humans; Male; Ornithine; Polyamines; Prostatic Neopl | 1985 |